Peter A. Thompson - Net Worth and Insider Trading

Over the past 18 months, Peter A. Thompson made no insider transaction in PMV Pharmaceuticals Inc (PMVP). Other recent insider transactions involving PMV Pharmaceuticals Inc (PMVP) include a net sale of 87,786 shares made by Orbimed Advisors Llc , a net sale of 6,291 shares made by Leila Alland , and a net sale of 4,104 shares made by Deepika Jalota .

In summary, during the past 3 months, insiders sold 0 shares of PMV Pharmaceuticals Inc (PMVP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 98,181 shares of PMV Pharmaceuticals Inc (PMVP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 98,181 shares.

PMV Pharmaceuticals Inc (PMVP)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Prevail Therapeutics Inc (PRVL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Prevail Therapeutics Inc (PRVL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Prevail Therapeutics Inc (PRVL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Peter A. Thompson made no insider transaction in Corvus Pharmaceuticals Inc (CRVS). Other recent insider transactions involving Corvus Pharmaceuticals Inc (CRVS) include a net purchase of 60,000 shares made by Miller Richard A Md , a net purchase of 34,000 shares made by Leiv Lea , and a net purchase of 20,000 shares made by William Benton Jones .

In summary, during the past 3 months, insiders sold 0 shares of Corvus Pharmaceuticals Inc (CRVS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Corvus Pharmaceuticals Inc (CRVS) were sold and 124,000 shares were bought by its insiders, resulting in a net purchase of 124,000 shares.

Corvus Pharmaceuticals Inc (CRVS)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Synthorx Inc (THOR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Synthorx Inc (THOR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Synthorx Inc (THOR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Peter A. Thompson made 1 insider transaction in Alpine Immune Sciences Inc (ALPN) with a net sale of 1,546,347. Other recent insider transactions involving Alpine Immune Sciences Inc (ALPN) include a net sale of 281,514 shares made by James Paul Rickey , a net sale of 213,302 shares made by Mitchell Gold , and a net sale of 1,546,347 shares made by Orbimed Advisors Llc .

In summary, during the past 3 months, insiders sold 118,000 shares of Alpine Immune Sciences Inc (ALPN) in total and bought 0 shares, with a net sale of 118,000 shares. During the past 18 months, 3,587,510 shares of Alpine Immune Sciences Inc (ALPN) were sold and 750,000 shares were bought by its insiders, resulting in a net sale of 2,837,510 shares.

Alpine Immune Sciences Inc (ALPN)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Principia Biopharma Inc (PRNB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Principia Biopharma Inc (PRNB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Principia Biopharma Inc (PRNB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Peter A. Thompson made no insider transaction in Adaptimmune Therapeutics PLC (ADAP). Other recent insider transactions involving Adaptimmune Therapeutics PLC (ADAP) include a net sale of 115,184 shares made by Adrian Rawcliffe , a net sale of 48,376 shares made by John Lunger , and a net sale of 46,074 shares made by Bertrand William C Jr .

In summary, during the past 3 months, insiders sold 0 shares of Adaptimmune Therapeutics PLC (ADAP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 315,048 shares of Adaptimmune Therapeutics PLC (ADAP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 315,048 shares.

Adaptimmune Therapeutics PLC (ADAP)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Response Biomedical Corp (RPBIF) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Response Biomedical Corp (RPBIF) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Response Biomedical Corp (RPBIF)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Sierra Oncology Inc (SRRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sierra Oncology Inc (SRRA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sierra Oncology Inc (SRRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Peter A. Thompson made no insider transaction in Mirati Therapeutics Inc (MRTX). Other recent insider transactions involving Mirati Therapeutics Inc (MRTX) include a net sale of 16,852 shares made by Jamie Christensen , a net sale of 12,809 shares made by Benjamin Hickey , and a net sale of 81,996 shares made by Charles M Baum .

In summary, during the past 3 months, insiders sold 0 shares of Mirati Therapeutics Inc (MRTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 126,645 shares of Mirati Therapeutics Inc (MRTX) were sold and 2,528,737 shares were bought by its insiders, resulting in a net purchase of 2,402,092 shares.

Mirati Therapeutics Inc (MRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Anthera Pharmaceuticals Inc (ANTH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Anthera Pharmaceuticals Inc (ANTH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Anthera Pharmaceuticals Inc (ANTH)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Decibel Therapeutics Inc (DBTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Decibel Therapeutics Inc (DBTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Decibel Therapeutics Inc (DBTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Silverback Therapeutics Inc (SBTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Silverback Therapeutics Inc (SBTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Silverback Therapeutics Inc (SBTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Peter A. Thompson made 1 insider transaction in Edgewise Therapeutics Inc (EWTX) with a net purchase of 454,545. Other recent insider transactions involving Edgewise Therapeutics Inc (EWTX) include a net sale of 40,229 shares made by John R Moore , a net sale of 174,187 shares made by Alan J Russell , and a net sale of 91,336 shares made by R Michael Carruthers .

In summary, during the past 3 months, insiders sold 129,835 shares of Edgewise Therapeutics Inc (EWTX) in total and bought 909,090 shares, with a net purchase of 779,255 shares. During the past 18 months, 323,956 shares of Edgewise Therapeutics Inc (EWTX) were sold and 919,947 shares were bought by its insiders, resulting in a net purchase of 595,991 shares.

Edgewise Therapeutics Inc (EWTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Peter A. Thompson made no insider transaction in Janux Therapeutics Inc (JANX). Other recent insider transactions involving Janux Therapeutics Inc (JANX) include a net purchase of 849,854 shares made by Tighe Reardon , a net purchase of 849,854 shares made by Avalon Ventures Xi, L.p. , and a net purchase of 849,854 shares made by Jay Lichter .

In summary, during the past 3 months, insiders sold 0 shares of Janux Therapeutics Inc (JANX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Janux Therapeutics Inc (JANX) were sold and 3,044,570 shares were bought by its insiders, resulting in a net purchase of 3,044,570 shares.

Janux Therapeutics Inc (JANX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Peter A. Thompson made 1 insider transaction in ARS Pharmaceuticals Inc (SPRY) with a net purchase of 500,000. Other recent insider transactions involving ARS Pharmaceuticals Inc (SPRY) include a net sale of 543,896 shares made by Laura Shawver , a net sale of 503,260 shares made by Sarina Tanimoto , and a net sale of 503,260 shares made by Richard E Lowenthal .

In summary, during the past 3 months, insiders sold 1,006,520 shares of ARS Pharmaceuticals Inc (SPRY) in total and bought 1,401,299 shares, with a net purchase of 394,779 shares. During the past 18 months, 1,550,416 shares of ARS Pharmaceuticals Inc (SPRY) were sold and 8,945,807 shares were bought by its insiders, resulting in a net purchase of 7,395,391 shares.

ARS Pharmaceuticals Inc (SPRY)'s detailed insider trading history can be found in Insider Trading Tracker table.